Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 National Institutes of Health Consensus Development Conference Statement: management of hepatitis B.

Literature DB >> 19124811

National Institutes of Health Consensus Development Conference Statement: management of hepatitis B.

Michael F Sorrell¹, Edward A Belongia, Jose Costa, Ilana F Gareen, Jean L Grem, John M Inadomi, Earl R Kern, James A McHugh, Gloria M Petersen, Michael F Rein, Doris B Strader, Hartwell T Trotter.

Abstract

Entities: Disease

Mesh：

Substances：
Antiviral Agents

Year: 2009 PMID： 19124811 DOI： 10.7326/0003-4819-150-2-200901200-00100

Source DB: PubMed Journal: Ann Intern Med ISSN： 0003-4819 Impact factor: 25.391

Keyword Cloud
Cited

× No keyword cloud information.

86 in total

1. Hepatitis B screening, prophylaxis and re-activation in the era of rituximab-based chemotherapy.

Authors: Jorge Méndez-Navarro; Kathleen E Corey; Hui Zheng; Lydia L Barlow; Jae Young Jang; Wenyu Lin; Hong Zhao; Run-Xuan Shao; Steven L McAfee; Raymond T Chung
Journal: Liver Int Date: 2010-08-25 Impact factor: 5.828

Review 2. When treating cancer, please don't forget hepatitis B.

Authors: Lindsay Y King; Raymond T Chung
Journal: Oncologist Date: 2010-07-20

3. Understanding the natural history of chronic HBV and HCV infections.

Authors: David L Thomas; Adrian M Di Bisceglie; Harvey J Alter; Norah A Terrault
Journal: J Fam Pract Date: 2010-04 Impact factor: 0.493

4. Combination treatment in HBeAg-negative chronic hepatitis B.

Authors: Konstantinos Tziomalos
Journal: World J Hepatol Date: 2009-10-31

5. Admissions for hepatitis B reactivation in patients receiving immunosuppressive therapy remain unchanged from 1999 to 2014.

Authors: Arpan Patel; Suna Yapali; Anna S F Lok
Journal: Hepatol Int Date: 2015-08-14 Impact factor: 6.047

Review 6. Hepatitis B therapy.

Authors: Hellan Kwon; Anna S Lok
Journal: Nat Rev Gastroenterol Hepatol Date: 2011-03-22 Impact factor: 46.802

National Institutes of Health Consensus Development Conference Statement: management of hepatitis B.

1. Hepatitis B screening, prophylaxis and re-activation in the era of rituximab-based chemotherapy.

Review 2. When treating cancer, please don't forget hepatitis B.

3. Understanding the natural history of chronic HBV and HCV infections.

4. Combination treatment in HBeAg-negative chronic hepatitis B.

5. Admissions for hepatitis B reactivation in patients receiving immunosuppressive therapy remain unchanged from 1999 to 2014.

Review 6. Hepatitis B therapy.

7. Evaluating Noninvasive Markers to Identify Advanced Fibrosis by Liver Biopsy in HBV/HIV Co-infected Adults.

Review 8. Entecavir: a review of its use in chronic hepatitis B.

Review 9. Technical standards for hepatitis B virus X protein (HBx) research.

10. Hepatitis B virus genetic diversity has minimal impact on sensitivity of the viral ribonuclease H to inhibitors.